Overview
Alissa Huston is a Hematologist and a Hematologist Oncology provider in Rochester, New York. Dr. Huston is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 Elmwood Ave, Box 684, Rochester, NY 14642
738 Library Rd, Rochester, NY 14642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Rochester
Patrick Reagan is a Hematologist and an Oncologist in Rochester, New York. Dr. Reagan has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of Rochester
Paul Barr is a Hematologist and an Oncologist in Rochester, New York. Dr. Barr is rated as an Elite provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of Rochester
Kristen O'dwyer is a Hematologist and a Transplant Surgeon in Rochester, New York. Dr. O'dwyer is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Chronic Myelomonocytic Leukemia (CMML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Huston isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Huston isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Huston isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Huston isDistinguished. Learn about Paget Disease of the Breast.
- Experienced
- Bone Marrow AspirationDr. Huston isExperienced. Learn about Bone Marrow Aspiration.
- Bone TumorDr. Huston isExperienced. Learn about Bone Tumor.
- BRCA Positive Breast CancerDr. Huston isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Huston isExperienced. Learn about Breast Cancer in Men.
- HER-2 Positive Breast CancerDr. Huston isExperienced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Huston isExperienced. Learn about HER2 Negative Breast Cancer.